Acorda Therapeutics Inc Beta
Cos'è Beta di Acorda Therapeutics Inc?
Beta di Acorda Therapeutics Inc è 0.59
Qual è la definizione di Beta?
BETA indica se una azione è più o meno volatile rispetto al mercato nel suo complesso. Un beta inferiore a 1 indica che la azione è meno volatile rispetto al mercato, mentre un beta più di 1 indica che la azione è più volatile. La volatilità è misurata come la fluttuazione del prezzo attorno alla media.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta di aziende nel Health Care settore su NASDAQ rispetto a Acorda Therapeutics Inc
Cosa fa Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Aziende con beta simili a Acorda Therapeutics Inc
- Columbia Sportswear Co ha Beta di 0.59
- REF ha Beta di 0.59
- Eon Electric ha Beta di 0.59
- Culp ha Beta di 0.59
- B.P. Marsh & Partners PLC ha Beta di 0.59
- Banco Bradesco S.A ha Beta di 0.59
- Acorda Therapeutics Inc ha Beta di 0.59
- Caribbean Utilities ha Beta di 0.59
- Branded Legacy Inc ha Beta di 0.59
- Icahn Enterprises L P ha Beta di 0.59
- Universal ha Beta di 0.59
- Hi Sun Technology (China) ha Beta di 0.59
- Texmaco Infrastructure & ha Beta di 0.59